Spinal muscular atrophy



All types of SMA are diagnosed through a blood test (genetic testing) to determine whether both copies of the SMN1 gene have a fault (deletion) responsible for SMA. A positive test will result in a diagnosis of 5q SMA.

Counting the number of SMN2 genes can be a helpful indicator for the prognosis of the condition (how it will develop). It can, therefore, guide the best care and management. The number of SMN2 copies can also be a factor in entry criteria for clinical trials.

Link to page 14-15 of the Guide to the 2017 International Standards of Care for SMA

Last modified
03 March 2020